| KEW Group Inc. (KEW) is revolutionizing cancer care by empowering oncologists with access to genomic insights to design optimal, individualized treatment approaches for patients. KEW Group’s comprehensive set of products and solutions are designed to provide clarity above the complexity of genome-guided, personalized cancer therapy, arming oncologists with knowledge, informing today’s treatment decisions, and guiding tomorrow’s new therapies. |